LSOSS: Detection of cancer outlier differential gene expression

Biomarker Insights

Volumn 2010, Issue 5, 2010, Pages 69-78

  Wang, Yupeng ^a   Rekaya, Romdhane ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cancer; Differential gene expression; Outlier

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CLUSTER ANALYSIS; CONTROLLED STUDY; GENE ACTIVATION; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; INTERMETHOD COMPARISON; LEAST SUM OF ORDERED SUBSET SQUARE T STATISTIC; MALE; MATHEMATICAL MODEL; ONCOGENE; PROCESS MODEL; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS;

EID: 77957132222     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/bmi.s5175     Document Type: Article

References (28)

1. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005; 310:644-8.
2. Tibshirani R, Hastie T. Outlier sums for differential gene expression analysis. Biostatistics. 2007;8:2-8.
3. Wu B. Cancer outlier differential gene expression detection. Biostatistics. 2007;8:566-75.
4. Lian H. MOST: detecting cancer differential gene expression. Biostatistics. 2008;9:411-8.
5. West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A. 2001;98:11462-7.
6. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A Comparison of Normalization Methods for High Density Oligonucleotide Array Data Based on Bias and Variance. Bioinformatics. 2003;19: 185-93.
7. Kuznetsova EB, Kekeeva TV, Larin SS, et al. Novel methylation and expression markers associated with breast cancer. Mol Biol (Mosk). 2007;41:624-33.
8. Lee JE, Kim HJ, Bae JY, et al. Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer. BMC Cancer. 2005; 5:154.
9. Gaugler B, van den Eynde B, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med. 1994;179:921-30.
10. Gómez-Esquer F, Agudo D, Martínez-Arribas F, Nuñez-Villar MJ, Schneider J. mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer. Anticancer Res. 2004;24: 1581-5.
11. Garib V, Lang K, Niggemann B, Zänker KS, Brandt L, Dittmar T. Propofolinduced calcium signalling and actin reorganization within breast carcinoma cells. Eur J Anaesthesiol. 2005;22:609-15.
12. Ye C, Cai Q, Dai Q, et al. Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival. Cancer. 2007; 109:1729-35.
13. Schneider J, Linares R, Martínez-Arribas F, et al. Developing chick embryos express a protein which shares homology with the nuclear pore complex protein Nup88 present in human tumors. Int J Dev Biol. 2004;48: 339-42.
14. Calaf GM, Roy D. Human drug metabolism genes in parathion-and estrogen- treated breast cells. Int J Mol Med. 2007;20:875-81.
15. Kunz-Schughart LA, Heyder P, Schroeder J, Knuechel R. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. Exp Cell Res. 2001; 266:74-86.
16. Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002;1:203-9.
17. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-64.
18. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res. 1996;56:1142-5.
19. Bull JH, Ellison G, Patel A, et al. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br J Cancer. 2001;84:1512-9.
20. Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle. 2006;5:1886-901.
21. Ficazzola MA, Fraiman M, Gitlin J, et al. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis. 2001;22:1271-9.
22. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. The significance of Elf-1 expression in epithelial ovarian carcinoma. Int J Mol Med. 2003;12: 349-54.
23. Bertucci F, Birnbaum D. Reasons for breast cancer heterogeneity. J Biol. 2008;7:6.
24. Anderson WF, Matsuno R. Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Ins. 2006;98:948-51.
25. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-52.
26. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869-74.
27. Sørlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418-23
28. Kapp AV, Jeffrey SS, Langerød A, et al. Discovery and validation of breast cancer subtypes. BMC Genomics. 2006;7:231.